Yawen Wang, Guojin Zhou, Liuxian Guo, Jing Xu, Jie Chen. "Clinical outcomes of first-line osimertinib in NSCLC patients with EGFR mutations.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e20649